Human stem cells patents-Emerging issues and challenges in Europe, United States, China, and Japan
http://api.archives-ouvertes.fr/search/?fq=halId_s:halshs-01756840&fl=title_s,en_title_s,docid,label_s,en_label_s,docType_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s,fileMain_s&sort=publicationDate_s+desc
authors
document type
ARTabstract
Stem cell technology is undergoing a rapid development for its high potential in versatile therapeutic applications. Patent protection is a vital factor affecting the development and commercial success of life sciences inventions; yet human stem cells-based inventions have been encountering significant restrictions particularly in the perspective of patentable subject matters. This article looks into the patentability limits and unique challenges for human stem cells-based patents in four regions: Europe, the United States, China and Japan. We will also provide suggestions for addressing the emerging issues in each region.